Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
- PMID: 8621715
- DOI: 10.1074/jbc.271.6.3154
Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR
Abstract
Here we show that the Escherichia coli expressed monomers of placenta growth factor (PLGF)129 and vascular endothelial growth factor (VEGF)165 can be re-folded in vitro to form PLGF/VEGF heterodimers. The purified recombinant PLGF/VEGF heterodimers and VEGF homodimers have potent mitogenic and chemotactic effects on endothelial cells. However, PLGF/VEGF heterodimers display 20-50-fold less mitogenic activity than VEGF165 homodimers. In contrast, PLGF129 homodimers have little or no effect in these in vitro assays. We also demonstrate the presence of natural PLGF/VEGF heterodimers in the conditioned media of various human tumor cell lines. While PLGF/VEGF heterodimers bind with high affinity to a soluble Flk-1/KDR receptor, PLGF129 homodimers fail to bind to this receptor. Cross-linking of 125I-ligands to human umbilical vein endothelial cells reveals that PLGF/VEGF heterodimers and VEGF165 homodimers, but not PLGF129 homodimers, form complexes with membrane receptors. VEGF165 homodimers and PLGF/VEGF heterodimers stimulate tyrosine phosphorylation of a 220-kDa protein, the expected size for the KDR receptor in human umbilical vein endothelial cells, whereas PLGF129 homodimers are unable to induce tyrosine phosphorylation of this protein. These data indicate that PLGF may modulate VEGF-induced angiogenesis by the formation of PLGF/VEGF heterodimers in cells producing both factors.
Similar articles
-
Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.Oncogene. 1997 Nov 27;15(22):2687-98. doi: 10.1038/sj.onc.1201456. Oncogene. 1997. PMID: 9400995
-
Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.J Biol Chem. 1995 Mar 31;270(13):7717-23. doi: 10.1074/jbc.270.13.7717. J Biol Chem. 1995. PMID: 7706320
-
Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain.J Biol Chem. 1996 Mar 8;271(10):5761-7. doi: 10.1074/jbc.271.10.5761. J Biol Chem. 1996. PMID: 8621443
-
The discovery of placenta growth factor and its biological activity.Exp Mol Med. 2012 Jan 31;44(1):1-9. doi: 10.3858/emm.2012.44.1.025. Exp Mol Med. 2012. PMID: 22228176 Free PMC article. Review.
-
An unexpected tail of VEGF and PlGF in pre-eclampsia.Biochem Soc Trans. 2011 Dec;39(6):1576-82. doi: 10.1042/BST20110671. Biochem Soc Trans. 2011. PMID: 22103490 Free PMC article. Review.
Cited by
-
PlGF: a multitasking cytokine with disease-restricted activity.Cold Spring Harb Perspect Med. 2012 Aug 1;2(8):a011056. doi: 10.1101/cshperspect.a011056. Cold Spring Harb Perspect Med. 2012. PMID: 22908198 Free PMC article. Review.
-
Overcoming resistance to antiangiogenic therapies.Oncologist. 2012;17(8):1039-50. doi: 10.1634/theoncologist.2012-0068. Epub 2012 Jul 6. Oncologist. 2012. PMID: 22773560 Free PMC article. Review.
-
Role of placenta growth factor in cancer and inflammation.Exp Mol Med. 2012 Jan 31;44(1):10-9. doi: 10.3858/emm.2012.44.1.023. Exp Mol Med. 2012. PMID: 22217448 Free PMC article. Review.
-
Soluble VEGFR-2: an antilymphangiogenic variant of VEGF receptors.Ann N Y Acad Sci. 2010 Oct;1207 Suppl 1(Suppl 1):E7-15. doi: 10.1111/j.1749-6632.2010.05714.x. Ann N Y Acad Sci. 2010. PMID: 20961309 Free PMC article.
-
Structural insights into the binding of vascular endothelial growth factor-B by VEGFR-1(D2): recognition and specificity.J Biol Chem. 2010 Jul 30;285(31):23779-89. doi: 10.1074/jbc.M110.130658. Epub 2010 May 25. J Biol Chem. 2010. PMID: 20501651 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources